Cardiovascular and Psychological Consequences of COVID-19
- Conditions
- Post-COVID Conditions
- Registration Number
- NCT05758649
- Lead Sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Brief Summary
The study will assess cardiac and psychological profile at 2-3 months after recovery from COVID-19 infection.
- Detailed Description
A significant proportion of patients hospitalized for COVID-19 showed laboratory signs of myocardial damage, detected by elevated troponin levels, and these were associated with more severe clinical course and higher mortality. Moreover, it is unknown how the health emergency and the associated conditions may have influenced and still influence the psychological experience of the affected people.
Thus, in order to promote continuity of care, post-COVID-19 disease clinics have therefore been activated dedicated to a specific follow-up program for monitoring long-term alterations and for the early identification of patients requiring rehabilitation.
The program includes a first follow-up visit (2-3 months after recovery) including cardiac (2D-echocardiography, six-minute walking test, autonomic function evaluation) and psychological (Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD) National Stressful Events Survey PTSD Short Scale (NSESSS)) evaluation.
A second follow-up visit will be performed at 12 months in the form of structured interview,
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 104
- Recent discharge (≤ 3 months) from a COVID+ ward for SARS-CoV-2 disease
- Serious clinical conditions (severe chronic inflammatory diseases, neoplasms, neurological pathologies).
- Non-Italian education, illiteracy, or return to illiteracy.
- Severe visual-perceptual deficits.
- Low motivation/interest or refusal to undergo the assessment.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence of patients with cardiovascular or psychological sequelae 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
ICS Maugeri
🇮🇹Pavia, Italy